Clinical Trial Update: Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia

View source ↗

Summary

A completed clinical trial evaluating Lestaurtinib with or without chemotherapy in young patients with childhood leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Acute Lymphoblastic Leukemia
• Childhood Acute Myeloid Leukemia

Drugs mentioned

• Lestaurtinib (lestaurtinib)

Snippet

Sponsor: Children's Oncology Group | Conditions: Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies | Status: COMPLETED